We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Merck KGaA Passes EXCiPACT Audit for Certification as Provider of Pharmaceutical Excipients

News   Aug 02, 2013

 
Merck KGaA Passes EXCiPACT Audit for Certification as Provider of Pharmaceutical Excipients
 
 
 

RELATED ARTICLES

Global Survey Reveals Lack of Ovarian Cancer Awareness

News

Massive global review presents a bleak picture of the challenges faced by women with ovarian cancer, and those who care for them.

READ MORE

Dual Anthrax-Plague Vaccine Effective in Multiple Animal Models

News

A dual vaccine against the causative agents of anthrax and the plague is effective in three animal models.

READ MORE

Marker May Help Target Treatments for Crohn’s Patients

News

Accurately predicting which subtype of Crohn's disease is likely to develop has not been possible, until now.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE